Pradaxa (dabigatran etexilate) - Recommendations for assessment of renal function and monitoring in the elderly
17 February 2012
Following a recent EU evaluation of all available safety data on the risk of fatal haemorrhage with Pradaxa, new recommendations to assess renal function prior to and during treatment with Pradaxa were introduced.
Pradaxa (dabigatran etexilate) - Recommendations for assessment of renal function and monitoring in the elderly